Literature DB >> 16261336

An evaluation of immediate sheath removal and use of the Angio-Seal vascular closure device in neuroradiological interventions.

L Pierot1, D Herbreteau, S Bracard, J Berge, C Cognard.   

Abstract

We set out to assess the effect of using an arteriotomy closure device in patients at high risk of access site complications. One-hundred nineteen patients with femoral artery access were prospectively included in five centers in France (56 males, 63 females, age range 20-84 years). The neurointerventional procedures were embolization of intracranial aneurysm (71.4%), carotid angioplasty (11.8%), cerebral angioplasty (1.7%), thrombolysis (0.8%), and other procedures (14.3%). Sheaths were removed and the closure device deployed immediately postprocedure. One patient developed a false aneurysm, and one developed a small hematoma. Neither required treatment. Postdevice deployment bleeding was experienced in three patients (2.5%), requiring minimal management. There were no major complications. Three patients died of causes unrelated to the vessel closure. Patient comfort was 2.2 on a scale of 1 (none) to 10 (severe). The results showed that immediate sheath removal followed by use of the closure device is safe in patients undergoing neurointerventional procedures and offers a low level of patient discomfort. In selected patients, early hospital discharge was possible.

Entities:  

Mesh:

Year:  2005        PMID: 16261336     DOI: 10.1007/s00234-005-0013-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

1.  Infectious complications of perclose for closure of femoral artery punctures.

Authors:  Donald V Heck; Sean Muldowney; Scott H McPherson
Journal:  J Vasc Interv Radiol       Date:  2002-04       Impact factor: 3.464

2.  Risk of local adverse events following cardiac catheterization by hemostasis device use and gender.

Authors:  Dale R Tavris; Beverly Albrecht Gallauresi; Ba Lin; Suzanne E Rich; Richard E Shaw; William S Weintraub; Ralph G Brindis; Kathleen Hewitt
Journal:  J Invasive Cardiol       Date:  2004-09       Impact factor: 2.022

3.  Neurointerventional experience with an arteriotomy suture device.

Authors:  P P Morris; G Braden
Journal:  AJNR Am J Neuroradiol       Date:  1999-10       Impact factor: 3.825

4.  Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.

Authors:  K Ouriel; B Gray; D G Clair; J Olin
Journal:  J Vasc Interv Radiol       Date:  2000-03       Impact factor: 3.464

5.  Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices.

Authors:  G Dangas; R Mehran; S Kokolis; D Feldman; L F Satler; A D Pichard; K M Kent; A J Lansky; G W Stone; M B Leon
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors.

Authors:  F S Resnic; G J Blake; L Ohno-Machado; A P Selwyn; J J Popma; C Rogers
Journal:  Am J Cardiol       Date:  2001-09-01       Impact factor: 2.778

7.  Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial.

Authors:  Bernard Chevalier; Bernard Lancelin; Rene Koning; Michel Henry; Antoine Gommeaux; Remy Pilliere; Meyer Elbaz; Thierry Lefevre; Kamel Boughalem; Jean Marco; Patrick Dupouy
Journal:  Catheter Cardiovasc Interv       Date:  2003-03       Impact factor: 2.692

8.  Procedural safety and short-term outcome of ambulatory carotid stenting.

Authors:  N Al-Mubarak; G S Roubin; J J Vitek; G New; S S Iyer
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

9.  Outpatient vascular intervention: a two-year experience.

Authors:  Sumaira Macdonald; Steven M Thomas; Trevor J Cleveland; Peter A Gaines
Journal:  Cardiovasc Intervent Radiol       Date:  2002-03-27       Impact factor: 2.740

10.  Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients.

Authors:  John Ducas; Michael C Y Chan; Anthony Miller; Tarek Kashour
Journal:  Catheter Cardiovasc Interv       Date:  2002-06       Impact factor: 2.692

View more
  6 in total

1.  Transcervical access via direct neck exposure for neurointerventional procedures in the hybrid angiosuite.

Authors:  Jong Young Lee; Jong-Hwa Park; Hong Jun Jeon; Dae Young Yoon; Seoung Woo Park; Byung Moon Cho
Journal:  Neuroradiology       Date:  2018-03-01       Impact factor: 2.804

2.  Delayed complication from a percutaneous vascular closure device following a neuro-interventional procedure.

Authors:  Ahmed Khaldi; B Waldau; C Skowlund; G J Velat; J Mocco; B L Hoh
Journal:  Interv Neuroradiol       Date:  2011-12-16       Impact factor: 1.610

3.  Safety profile of an 8F femoral arteriotomy closure using the Angio-Seal device in thrombolysed acute stroke patients undergoing thrombectomy.

Authors:  James Wareham; Sebastian Luppe; Adam Youssef; Robert Crossley; Alex Mortimer
Journal:  Interv Neuroradiol       Date:  2018-06-05       Impact factor: 1.610

4.  The safety and efficacy of the Angio-Seal closure device in diagnostic and interventional neuroangiography setting: a single-center experience with 1,443 closures.

Authors:  Serdar Geyik; Kivilcim Yavuz; Ayca Akgoz; Osman Koc; Bora Peynircioglu; Barbaros Cil; Saruhan Cekirge; Isil Saatci
Journal:  Neuroradiology       Date:  2007-06-27       Impact factor: 2.804

5.  Prospective comparison of angio-seal versus manual compression for hemostasis after neurointerventional procedures under systemic heparinization.

Authors:  H-F Wong; C-W Lee; Y-L Chen; Y-M Wu; H-H Weng; Y-H Wang; H-M Liu
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

6.  Safety and efficacy of Angio-Seal device for transfemoral neuroendovascular procedures: A systematic review and meta-analysis.

Authors:  Muhammed Amir Essibayi; Harry Cloft; Luis E Savastano; Waleed Brinjikji
Journal:  Interv Neuroradiol       Date:  2021-02-18       Impact factor: 1.764

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.